CT
Healthcare & Life Sciences
Cognition Therapeutics
United Statescogrx.com/
Cognition Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Cognition Therapeutics
Cognition Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Cognition Therapeutics develops therapies to protect neurons and preserve synaptic function in patients with neurodegenerative diseases, focusing on age-related conditions such as Alzheimer's disease and dementia with Lewy bodies.
Explore Cognition Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.